Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Complete Revascularisation in STEMI: Do We Really Buy It?
Author(s): Tevin Browne , Richard J Jabbour , Nick Curzen Added: 1 week ago

Imaging & Diagnostics

Intervention
ACC 26: FAST III - FFR vs vFFR to Guide Revascularisation
Author(s): Joost Daemen Added: 1 month ago
American College of Cardiology Congress 2026 - Dr Joost Daemen (Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL) joins us to discuss findings from the FAST III trial (NCT04931771; ECRI) a large-scale randomised study comparing fractional flow reserve (FFR) with 3D-quantitative coronary angiography-derived vessel FFR (vFFR) to guide coronary revascularisation.This randomised, open… View more

Intervention
Complete Revascularisation Following Acute MI
Author(s): Ahmed Gonnah , Nadhrah Darke , Liam Mullen , et al Added: 1 year ago

MI/ACS

Prevention & Chronic Conditions
Post-revascularisation de Winter Pattern
Author(s): Shairah Ridzuan Aw , Raja Ezman Raja Shariff Added: 5 months ago

Intervention

MI/ACS
OPTION-STEMI: Staged Revascularisation for STEMI with HF
Added: 1 month ago Source:  Cardiac Failure Review
The optimal timing for complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multi-vessel disease who also present with heart failure is a key clinical question. A pre-specified subgroup analysis of the OPTION-STEMI trial suggests that a staged approach may be preferable to immediate complete revascularisation in this high-risk patient group… View more

Intervention

MI/ACS
EuroPCR 25: The DANAMI-3-PRIMULTI Trial
Author(s): Thomas Engstrøm Added: 12 months ago
EuroPCR 25 - 10-year outcomes from DANAMI-3-PRIMULTI show FFR-guided complete revascularisation in ST-elevation myocardial infarction (STEMI) reduces the risk of future events. We are joined by Dr Thomas Engstrøm (University of Copenhagen, Copenhagen, Denmark) to discuss 10-year outcomes from the multicenter, randomized DANAMI-3-PRIMULTI trial investigating FFR-guided complete… View more

Demographic

MI/ACS
OPTION–STEMI: Immediate Complete Revascularisation Fails to Show Non-Inferiority to Staged Approach
Added: 8 months ago Source:  Transcatheter Academy
The optimal timing for complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains a topic of clinical debate.¹˒² The OPTION–STEMI trial aimed to determine whether an immediate complete revascularisation strategy was non-inferior to a staged approach performed during the same index hospital admission.¹OPTION–STEMI… View more

Guidelines & Statements

Intervention
Stenting Strategies in Left Main Bifurcation
Author(s): Suryono Suryono , Muhammad Farhan Hibatulloh , Alfiyah Ramadhani , et al Added: 3 months ago

Intervention

Vascular Disease and Surgery
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 8 months ago

Intervention

Prevention & Chronic Conditions
ESC 24: The EARTH-STEMI Meta-Analysis
Author(s): Gianluca Campo Added: 1 year ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in… View more

Intervention